| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Internal Medicine I, Faculty of Medicine, Oita University, Hasama, Oita 879-5593, Japan
Address all correspondence and requests for reprints to: Professor Hironobu Yoshimatsu, M.D., Ph.D., Department of Internal Medicine I, Faculty of Medicine, Oita University, 11 Idaigaoka, Hasama, Oita 879-5593, Japan. E-mail: hiroy{at}oita-med.ac.jp.
This study examined how orexin regulates the activity of the sympathetic nerves that innervate brown adipose tissue (BAT) in rats. Infusion of orexin A at a dose of 0.3 nmol into the third cerebral ventricle decreased BAT sympathetic nerve activity, compared with the effect of PBS (P < 0.05), whereas infusion of orexin B at the same dose caused a significant increase (P < 0.05). Pretreatment with a third cerebral ventricle injection of 2.24 µmol/kg
-fluoromethylhistidine, an irreversible inhibitor of the histamine-synthesizing enzyme histidine decarboxylase, attenuated the orexin B-induced response of BAT sympathetic nerve activity, but not that induced by orexin A. These results indicate that orexins may regulate both BAT energy expenditure and thermogenesis through their dual effects on sympathetic nerve activity. In particular, orexin B regulates BAT sympathetic nerve activity via neuronal histamine in the hypothalamus.
This article has been cited by other articles:
![]() |
H. L. Haas, O. A. Sergeeva, and O. Selbach Histamine in the Nervous System Physiol Rev, July 1, 2008; 88(3): 1183 - 1241. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Silveyra, V. Lux-Lantos, and C. Libertun Both orexin receptors are expressed in rat ovaries and fluctuate with the estrous cycle: effects of orexin receptor antagonists on gonadotropins and ovulation Am J Physiol Endocrinol Metab, October 1, 2007; 293(4): E977 - E985. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Shi, A. D. Strader, S. C. Woods, and R. J. Seeley Sexually dimorphic responses to fat loss after caloric restriction or surgical lipectomy Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E316 - E326. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tanida, A. Niijima, J. Shen, S. Yamada, H. Sawai, Y. Fukuda, and K. Nagai Dose-different effects of orexin-a on the renal sympathetic nerve and blood pressure in urethane-anesthetized rats. Experimental Biology and Medicine, November 1, 2006; 231(10): 1616 - 1625. [Abstract] [Full Text] [PDF] |
||||
![]() |
J E Digby, J Chen, J Y Tang, H Lehnert, R N Matthews, and H S Randeva Orexin receptor expression in human adipose tissue: effects of orexin-A and orexin-B. J. Endocrinol., October 1, 2006; 191(1): 129 - 136. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Koban, W. W. Le, and G. E. Hoffman Changes in Hypothalamic Corticotropin-Releasing Hormone, Neuropeptide Y, and Proopiomelanocortin Gene Expression during Chronic Rapid Eye Movement Sleep Deprivation of Rats Endocrinology, January 1, 2006; 147(1): 421 - 431. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |